HLA-DRB1, -DQB1 alleles in head and neck carcinoma patients

Tissue Antigens

Volumn 67, Issue 3, 2006, Pages 237-240

  Koskinen, W J ^a,b   Partanen, J ^c   Vaheri, A ^a   Aaltonen, L M ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c FINNISH RED CROSS BLOOD SERVICE   (Finland)

Author keywords

Head and neck cancer; HLA class II

Indexed keywords

HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ALLELE; ARTICLE; CANCER RELAPSE; CARCINOGENESIS; CONTROLLED STUDY; GENE FREQUENCY; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; IMMUNITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UTERINE CERVIX CANCER; WART VIRUS;

ALLELES; GENE FREQUENCY; HAPLOTYPES; HEAD AND NECK NEOPLASMS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; RETROSPECTIVE STUDIES;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES;

EID: 33644901569     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2006.00558.x     Document Type: Article

References (28)

1. Klein J Sato A The HLA system. First of two parts N Engl J Med 2000 343 702 9
2. Klein J Sato A The HLA system. Second of two parts N Engl J Med 2000 343 782 6
3. Schiffman MH Bauer HM Hoover RN et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia J Natl Cancer Inst 1993 85 958 64
4. Wang SS Wheeler CM Hildesheim A et al. Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica J Infect Dis 2001 184 1310 4
5. Neuman RJ Huettner PC Li L et al. Association between DQB1 and cervical cancer in patients with human papillomavirus and family controls Obstet Gynecol 2000 95 134 40
6. Apple RJ Erlich HA Klitz W Manos MM Becker TM Wheeler CM HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity Nat Genet 1994 6 157 62
7. Dao DD Sierra-Torres CH Robazetti SC et al. HLA-DQB1 and cervical cancer in Venezuelan women Gynecol Oncol 2005 96 349 54
8. Madeleine MM Brumback B Cushing-Haugen KL et al. Human leukocyte antigen class II and cervical cancer risk: a population-based study J Infect Dis 2002 186 1565 74
9. Cuzick J Terry G Ho L et al. Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women Br J Cancer 2000 82 1348 52
10. Lin P Koutsky LA Critchlow CW et al. HLA class II DR-DQ and increased risk of cervical cancer among Senegalese women Cancer Epidemiol Biomarkers Prev 2001 10 1037 45
11. Hildesheim A Wang SS Host and viral genetics and risk of cervical cancer: a review Virus Res 2002 89 229 40
12. Montoya L Saiz I Rey G Vela F Clerici-Larradet N Cervical carcinoma: human papillomavirus infection and HLA-associated risk factors in the Spanish population Eur J Immunogenet 1998 25 329 37
13. Beskow AH Josefsson AM Gyllensten UB HLA class II alleles associated with infection by HPV16 in cervical cancer in situ Int J Cancer 2001 93 817 22
14. Gregoire L Lawrence WD Kukuruga D Eisenbrey AB Lancaster WD Association between HLA-DQB1 alleles and risk for cervical cancer in African-American women Int J Cancer 1994 57 504 7
15. Sanjeevi CB Hjelmstrom P Hallmans G et al. Different HLA-DR-DQ haplotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type-16 seropositive and seronegative Swedish women Int J Cancer 1996 68 409 14
16. Helland A Olsen AO Gjoen K et al. An increased risk of cervical intra-epithelial neoplasia grade II-III among human papillomavirus positive patients with the HLA-DQA1*0102-DQB1*0602 haplotype: a population-based case-control study of Norwegian women Int J Cancer 1998 76 19 24
17. Krul EJ Schipper RF Schreuder GM Fleuren GJ Kenter GG Melief CJ HLA and susceptibility to cervical neoplasia Hum Immunol 1999 60 337 42
18. Apple RJ Becker TM Wheeler CM Erlich HA Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma J Natl Cancer Inst 1995 87 427 36
19. Koskinen WJ Chen RW Leivo I et al. Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck Int J Cancer 2003 107 401 6
20. Chen R Sehr P Waterboer T et al. Presence of DNA of human papillomavirus 16 but no other types in tumor-free tonsillar tissue J Clin Microbiol 2005 43 1408 10
21. Chen R Aaltonen LM Vaheri A Human papillomavirus type 16 in head and neck carcinogenesis Rev Med Virol 2005 15 351 63
22. Aaltonen LM Partanen J Auvinen E Rihkanen H Vaheri A HLA-DQ alleles and human papillomavirus DNA in adult-onset laryngeal papillomatosis J Infect Dis 1999 179 682 5
23. Bonagura VR Vambutas A DeVoti JA et al. HLA alleles, IFN-gamma responses to HPV-11 E6, and disease severity in patients with recurrent respiratory papillomatosis Hum Immunol 2004 65 773 82
24. Gregoire L Reidy PM Rabah R Lancaster WD HLA-DQ alleles in white and African American patients with juvenile-onset recurrent respiratory papillomatosis Arch Otolaryngol Head Neck Surg 2003 129 1221 4
25. Tisch M Kyrberg H Weidauer H et al. Human leukocyte antigens and prognosis in patients with head and neck cancer: results of a prospective follow-up study Laryngoscope 2002 112 651 7
26. Sikorska B Danilewicz M Wagrowska-Danilewicz M HLA-DR expression is a significant prognostic factor in laryngeal cancer. A morphometric study APMIS 1999 107 383 8
27. Snijders PJ Cromme FV van den Brule AJ et al. Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology Int J Cancer 1992 51 845 50
28. Venuti A Badaracco G Rizzo C Mafera B Rahimi S Vigili M Presence of HPV in head and neck tumours: high prevalence in tonsillar localization J Exp Clin Cancer Res 2004 23 561 6